Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 120Lymphoma 90Lymphoma, Large B-Cell, Diffuse 79Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Burkitt Lymphoma 31Leukemia 27Multiple Myeloma 26Lymphoma, Non-Hodgkin 26Lymphoma, Follicular 26Hodgkin Disease 24Lymphoma, Mantle-Cell 18Neoplasms 16Lymphoma, T-Cell, Peripheral 16Lymphoma, B-Cell 14Lymphoma, Large-Cell, Immunoblastic 12Lymphoma, Large-Cell, Anaplastic 11Dendritic Cell Sarcoma, Interdigitating 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Recurrence 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8Neoplasms, Plasma Cell 7Neoplasm Metastasis 7Waldenstrom Macroglobulinemia 6Primary Myelofibrosis 6Lymphoma, T-Cell 6Immunoblastic Lymphadenopathy 6HIV Infections 5Graft vs Host Disease 5Blast Crisis 5

Interventions

fludarabine phosphate 8Cyclophosphamide 7Peripheral Blood Stem Cell Transplantation 6Mycophenolic Acid 6Whole-Body Irradiation 5Cyclosporine 5Tacrolimus 4Methotrexate 4Alemtuzumab 4Rituximab 3thymoglobulin 2fludarabine 2Transplantation 2Radiotherapy 2Melphalan 2Epoetin Alfa 2Cyclosporins 2Busulfan 2Antilymphocyte Serum 2tipifarnib 1ruxolitinib 1nelarabine 1merphos 1blinatumomab 1aldesleukin 1Thiotepa 1Therapeutics 1Thalidomide 1Sunitinib 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Large Granular Lymphocytic × Prednisone × Clear all
NCT00003910 2023-07-05

Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

Eastern Cooperative Oncology Group

Phase 2 Terminated
59 enrolled 8 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Large Granular Lymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡